以岭药业
(002603)
| 流通市值：231.63亿 | | | 总市值：281.18亿 |
| 流通股本：13.76亿 | | | 总股本：16.71亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 907,308,781.74 | 1,223,754,773.95 | 1,189,759,394.17 | 940,512,433.11 |
| 应收票据及应收账款 | 2,778,342,773.44 | 2,749,902,737.02 | 2,563,253,983.14 | 2,405,186,364.09 |
| 其中：应收票据 | - | - | - | 4,000,000 |
| 应收账款 | 2,778,342,773.44 | 2,749,902,737.02 | 2,563,253,983.14 | 2,401,186,364.09 |
| 应收款项融资 | 309,275,555.81 | 359,464,059.74 | 545,867,101.15 | 191,236,561.08 |
| 预付款项 | 148,349,186.5 | 139,821,766.74 | 112,267,739.34 | 109,711,768.3 |
| 其他应收款合计 | 26,147,007.82 | 10,348,016.22 | 5,918,714.53 | 5,353,425.74 |
| 存货 | 1,940,905,922.51 | 1,917,473,001.84 | 2,000,817,416.52 | 2,458,692,034.9 |
| 其他流动资产 | 64,245,435.29 | 136,648,048.29 | 125,072,845.23 | 227,084,539.35 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 6,183,574,663.11 | 6,537,412,403.8 | 6,656,361,082.97 | 6,543,745,737.68 |
| 非流动资产: | | | | |
| 长期股权投资 | 2,473,669.45 | 2,475,740.87 | 2,479,046.66 | 2,481,949.7 |
| 其他非流动金融资产 | 1,654,224,055.55 | 1,640,728,750.01 | 1,624,371,895.85 | 1,648,274,986.09 |
| 投资性房地产 | 23,362,180.68 | 23,848,899.72 | 19,293,447.54 | 24,822,337.79 |
| 固定资产 | 5,943,728,874.87 | 5,940,508,866.36 | 5,982,191,721.86 | 5,814,542,211.85 |
| 在建工程 | 1,360,710,102.69 | 1,342,088,187.19 | 1,316,911,718.61 | 1,470,586,376.3 |
| 生产性生物资产 | 4,678,433.31 | 6,014,703.27 | 5,444,068.85 | 5,554,078.72 |
| 使用权资产 | 23,783,360.63 | 25,365,245.25 | 19,351,230.25 | 20,533,084.09 |
| 无形资产 | 721,234,341.11 | 728,737,426.93 | 736,339,215.4 | 743,520,070.48 |
| 开发支出 | 216,741,614.94 | 200,941,907.43 | 191,836,358.99 | 185,466,046.75 |
| 商誉 | 111,071,625.41 | 112,630,807.42 | 114,189,989.42 | 115,749,171.43 |
| 长期待摊费用 | 4,709,763.66 | 3,148,675.04 | 3,411,843.63 | 3,900,184.9 |
| 递延所得税资产 | 147,517,900.93 | 163,931,928.28 | 176,367,787.32 | 183,579,721.29 |
| 其他非流动资产 | 216,274,124.64 | 223,692,658.54 | 279,921,378.19 | 216,570,579.82 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 10,430,510,047.87 | 10,414,113,796.31 | 10,472,109,702.57 | 10,435,580,799.21 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 16,614,084,710.98 | 16,951,526,200.11 | 17,128,470,785.54 | 16,979,326,536.89 |
| 流动负债: | | | | |
| 短期借款 | 600,285,250 | 460,257,250 | 600,362,777.78 | 600,348,611.09 |
| 应付票据及应付账款 | 2,548,056,190.23 | 2,552,473,230.42 | 2,711,241,381.94 | 2,846,544,255.16 |
| 其中：应付票据 | 592,562,046.78 | 629,839,883.08 | 756,690,921.2 | 722,789,037.34 |
| 应付账款 | 1,955,494,143.45 | 1,922,633,347.34 | 1,954,550,460.74 | 2,123,755,217.82 |
| 合同负债 | 173,514,006.27 | 272,849,117.72 | 337,123,560.07 | 287,521,441.18 |
| 应付职工薪酬 | 206,079,385.46 | 234,742,351.77 | 249,711,905.82 | 281,153,708.46 |
| 应交税费 | 90,126,071.55 | 104,251,989.37 | 138,649,775.22 | 169,890,234.98 |
| 其他应付款合计 | 306,333,411.48 | 535,536,060.99 | 31,896,739.33 | 43,199,868.56 |
| 应付股利 | 274,080,027.06 | 501,211,612.8 | - | - |
| 一年内到期的非流动负债 | 3,016,704.75 | 203,689,476.84 | 203,051,901.31 | 206,616,168.9 |
| 其他流动负债 | 10,342,292.56 | 10,566,800.99 | 13,536,166.29 | 11,426,867.23 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 3,937,753,312.3 | 4,374,366,278.1 | 4,285,574,207.76 | 4,446,701,155.56 |
| 非流动负债: | | | | |
| 长期借款 | 667,102,581.96 | 598,395,160.99 | 598,731,962.2 | 599,100,000 |
| 租赁负债 | 20,694,050.94 | 21,748,513.01 | 14,827,189.95 | 13,014,412.07 |
| 递延收益 | 375,591,062.28 | 364,693,665.36 | 358,929,984.9 | 352,373,820.38 |
| 递延所得税负债 | 127,301,379.82 | 128,892,043.98 | 130,525,711.7 | 130,141,948.91 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,190,689,075 | 1,113,729,383.34 | 1,103,014,848.75 | 1,094,630,181.36 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 5,128,442,387.3 | 5,488,095,661.44 | 5,388,589,056.51 | 5,541,331,336.92 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,670,705,376 | 1,670,705,376 | 1,670,705,376 | 1,670,705,376 |
| 资本公积 | 2,342,780,896.14 | 2,342,780,896.14 | 2,342,780,896.14 | 2,342,780,896.14 |
| 其他综合收益 | -6,061,313.13 | -6,592,620.27 | -6,646,366.43 | -6,613,196.88 |
| 盈余公积 | 936,762,403.7 | 936,762,403.7 | 936,762,403.7 | 936,762,403.7 |
| 未分配利润 | 6,559,652,068.16 | 6,535,332,333.9 | 6,810,014,756.29 | 6,506,086,837.55 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 11,503,839,430.87 | 11,478,988,389.47 | 11,753,617,065.7 | 11,449,722,316.51 |
| 少数股东权益 | -18,197,107.19 | -15,557,850.8 | -13,735,336.67 | -11,727,116.54 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 11,485,642,323.68 | 11,463,430,538.67 | 11,739,881,729.03 | 11,437,995,199.97 |
| 负债和股东权益合计 | 16,614,084,710.98 | 16,951,526,200.11 | 17,128,470,785.54 | 16,979,326,536.89 |
| 公告日期 | 2024-10-29 | 2024-08-28 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |